Acceptance and Commitment Therapy for people living with motor neuron disease: the COMMEND feasibility study and randomised controlled trial
Rebecca L. Gould(The London College), C. McDermott(University of Sheffield), Kirsty Weeks(Faculty (United Kingdom)), Pavithra Kumar(University of Sheffield), Tracey Young(University of Sheffield), Marc Serfaty(Faculty (United Kingdom)), Ammar Al‐Chalabi(King's College London), Robert Howard(University College London), Laura H. Goldstein(Boston Medical Center), Christopher D. Graham(NHS Lothian), Emily Turton(University of Sheffield), Charlotte Rawlinson(University College London), Matthew Bursnall(University of Sheffield), Lance M. McCracken(Uppsala University), David White(University of Sheffield), Benjamin J. Thompson(University of Sheffield), Simon Waterhouse(University of Sheffield), Mike Bradburn(University of Sheffield), Pamela J. Shaw(University of Sheffield), Rebecca Gossage-Worrall(University of Sheffield), Vanessa Lawrence(King's College London), Nicola Drewry, Cindy Cooper(Department of Health and Social Care), Dynameni Androulaki-Koraki(King's College London), Anju Keetharuth
Cited by 0
Related Papers
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
|Statistical Methods in Medical Research|2015|2k
What is a pilot or feasibility study? A review of current practice and editorial policy
|BMC Medical Research Methodology|2010|1.6k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980
Plastic waste associated with disease on coral reefs
|Science|2018|844
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774